| http://www.w3.org/ns/prov#value | - In accordance with the present invention it is envisaged that patients phenotypically or genotypically diagnosed as extensive metabolizers of racemic tramadol will particularly benefit from administration of substantially single enantiomer (???)-tramadol, since they are especially prone to suffering from side-effects such as nausea and vomiting.
|
